CGI-69 compositions and methods of use

Details for Australian Patent Application No. 2001268715 (hide)

Owner Genentech, Inc. CuraGen Corporation

Inventors Lewin, David; Yu, Xing Xian; Adams, Sean H.

Agent Griffith Hack

Pub. Number AU-B-2001268715

PCT Pub. Number WO01/98355

Priority 60/213,307 22.06.00 US

Filing date 22 June 2001

Wipo publication date 2 January 2002

Acceptance publication date 11 January 2007

International Classifications

C07K 14/47 (2006.01) Peptides having more than 20 amino acids

A61P 3/00 (2006.01) Drugs for disorders of the metabolism

A61P 3/04 (2006.01) Drugs for disorders of the metabolism

C12N 15/12 (2006.01) Mutation or genetic engineering - Genes encoding animal proteins

C12Q 1/68 (2006.01) Measuring or testing processes involving enzymes or micro-organisms - involving nucleic acids

G01N 33/50 (2006.01) Investigating or analysing materials by specific methods not covered by groups - Chemical analysis of biological material, e.g. blood, urine

A61K 38/00 (2006.01) Medicinal preparations containing peptides

A61K 48/00 (2006.01) Medicinal preparations containing genetic material which is inserted into cells of the living body to treat genetic diseases

Event Publications

11 January 2007 Application Accepted

  Published as AU-B-2001268715

10 May 2007 Standard Patent Sealed

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2001268716

2001268714-EV-VEGF nucleic acids and polypeptides and methods of use